Product Information
RYCLORA 2 MG/5 ML SOLUTION is a brand (anda) product labeled by CARWIN PHARMACEUTICAL ASSOCIATES, LLC, priced at $2.9021 per ML under NDC 15370015004. Its NADAC has been published 107 times since Sep 18, 2024.
FDA first approved this application on Jul 16, 2018.
Strength
2 mg/5mL
Manufacturer
CARWIN PHARMACEUTICAL ASSOCIATES, LLCNDC
15370015004
Classification
Brand (ANDA)
Dosage Form
LIQUID
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
DEXCHLORPHENIRAMINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA202520FDA Approved
7/16/2018
On Market Since
10/7/2018
Price Statistics
The NADAC for RYCLORA 2 MG/5 ML SOLUTION has been published 107 times since Sep 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9021 per ML |
|---|---|
| All-time high | $2.9021 (Sep 30, 2026) |
| All-time low | $2.8504 (Aug 20, 2025) |
| 52-week high | $2.9021 |
| 52-week low | $2.8504 |
| Median price | $2.8533 |
| Average price | $2.8689 |
| Largest weekly change | +1.8% (Feb 18, 2026) |
| Weeks tracked | 107 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dexchlorpheniramine Maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
CARWIN PHARMACEUTICAL ASSOCIATES, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexchlorpheniramine Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RYCLORA 2 MG/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for RYCLORA 2 MG/5 ML SOLUTION, manufactured by CARWIN PHARMACEUTICAL ASSOCIATES, LLC, is $2.9021 per ML (NDC 15370015004), effective Sep 30, 2026.
How has the price of RYCLORA 2 MG/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for RYCLORA 2 MG/5 ML SOLUTION has held within roughly two percent of its current level. It has been tracked across 107 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for RYCLORA 2 MG/5 ML SOLUTION?
Since Sep 18, 2024, the NADAC for RYCLORA 2 MG/5 ML SOLUTION has ranged from a low of $2.8504 (Aug 20, 2025) to a high of $2.9021 (Sep 30, 2026), with a median of $2.8533 per ML.
Are there cheaper alternatives to RYCLORA 2 MG/5 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of RYCLORA 2 MG/5 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RYCLORA 2 MG/5 ML SOLUTION?
RYCLORA 2 MG/5 ML SOLUTION (NDC 15370015004) is labeled by CARWIN PHARMACEUTICAL ASSOCIATES, LLC, and CMS classifies it as a brand (anda) product.